Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

4.95
Delayed Data
As of 3:59pm ET
 +0.20 / +4.21%
Today’s Change
2.40
Today|||52-Week Range
6.45
+57.14%
Year-to-Date
Why Is Flexion Falling, and Other Questions
Oct 11 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close4.75
Today’s open4.75
Day’s range4.60 - 5.05
Volume723,125
Average volume (3 months)1,036,332
Market cap$148.9M
Dividend yield--
Data as of 3:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-15.53%
Earnings growth (this year)+37.25%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales8.52
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...-0.22-4.14%
VRNAVerona Pharma PLC+0.37+2.49%
NTECIntec Pharma Ltd0.000.00%
STDYSteadymed Ltd-0.05-1.56%
Data as of 3:59pm ET, 10/17/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.4M
Net profit margin-300.24%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Dennis J. Carlo
Vice President-
Operations
Karen K. Daniels
Corporate headquarters
San Diego, California

Forecasts